Literature DB >> 19182918

Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.

Ioanna Kousiappa1, David A M C van de Vijver, Ioannis Demetriades, Leondios G Kostrikis.   

Abstract

Abstract The molecular epidemiology of HIV-1 infection was first studied in Cyprus in the mid-1990s, but the extent of HIV-1 diversity and the prevalence of drug resistance have remained elusive. In an effort to address this issue, the present study examined HIV-1 strains isolated from 37 newly diagnosed untreated HIV-1 patients, representing 72% of the total number of newly diagnosed and drug-naive patients in the period 2003 to 2006. DNA sequences encoding the gag (p17, p24, p2, p7, p1, and p6), pol (protease and reverse transcriptase), and env (gp160) regions were amplified by RT-PCR from plasma HIV-1 RNA from all patients and sequenced using a newly designed methodology. All amplified products were studied according to established genetic methodologies to determine the genetic subtype and the prevalence of drug-resistance-associated mutations to currently available antiretroviral drugs. Analyses of the obtained viral sequences indicated that subtype A was the most common subtype present and accounted for 38% of the infections followed by subtype B (35%), subtype C (13%), CRF02_AG (8%), and subtypes D and CRF01_AE (3% each). One patient (2.7%) had an M41L/M and another patient (2.7%) an M184V amino acid substitution in the reverse transcriptase (RT) associated with high-level resistance to RT inhibitors. There were no patients with resistant mutations to protease inhibitors (PI). Additionally, one patient (2.7%) had an L44M amino acid substitution within the HR1 region of gp41 conferring resistance to the enfuvirtide (T20) fusion inhibitor. Similar to results of the 1994 molecular epidemiological study, these data demonstrate the extensive heterogeneity of HIV-1 infection in Cyprus and the low prevalence of transmitted resistance to current HIV-1 antiretroviral drugs. Taken together, these findings demonstrate that HIV-1 infection in Cyprus is being replenished by a continuous influx of new strains from many countries, establishing an ever-evolving and polyphyletic infection in the island.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182918     DOI: 10.1089/aid.2008.0168

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

Review 1.  Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

Authors:  Sonya J Snedecor; Lavanya Sudharshan; Katherine Nedrow; Abhijeet Bhanegaonkar; Kit N Simpson; Seema Haider; Richard Chambers; Charles Craig; Jennifer Stephens
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

2.  Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men.

Authors:  Zoi-Anna Antoniadou; Ioanna Kousiappa; Lemonia Skoura; Dimitris Pilalas; Simeon Metallidis; Pavlos Nicolaidis; Nicolaos Malisiovas; Leondios G Kostrikis
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-18       Impact factor: 2.205

3.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

4.  Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe.

Authors:  Victoria L Demetriou; David A M C van de Vijver; Ioanna Kousiappa; Claudia Balotta; Bonaventura Clotet; Zehava Grossman; Louise B Jørgensen; Snjezana Z Lepej; Itzchak Levy; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Francois Roman; Lidia Ruiz; Jean-Claude Schmidt; Anne-Mieke Vandamme; Kristel Van Laethem; Jurgen Vercauteren; Leondios G Kostrikis
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

5.  Origin and dynamics of HIV-1 subtype C infection in India.

Authors:  Chengli Shen; Jodi Craigo; Ming Ding; Yue Chen; Phalguni Gupta
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

6.  Major HIV resistance mutations in untreated Romanian patients.

Authors:  A Temereanca; L Ene; D Duiculescu; S Ruta
Journal:  J Med Life       Date:  2011-05-25

7.  Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Authors:  Victoria L Demetriou; Leondios G Kostrikis
Journal:  BMC Res Notes       Date:  2011-10-31

8.  HIV-1 transmission networks across Cyprus (2010-2012).

Authors:  Leondios G Kostrikis; Johana Hezka; Dora C Stylianou; Evangelia Kostaki; Maria Andreou; Ioanna Kousiappa; Dimitrios Paraskevis; Ioannis Demetriades
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

9.  HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.

Authors:  Fabien Roch Niama; Nicole Vidal; Halimatou Diop-Ndiaye; Etienne Nguimbi; Gabriel Ahombo; Philippe Diakabana; Édith Sophie Bayonne Kombo; Pembe Issamou Mayengue; Simon-Charles Kobawila; Henri Joseph Parra; Coumba Toure-Kane
Journal:  BMC Res Notes       Date:  2017-07-05

10.  HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012.

Authors:  Andrea-Clemencia Pineda-Peña; Kristof Theys; Dora C Stylianou; Ioannis Demetriades; Ana B Abecasis; Leondios G Kostrikis
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.